Clover Health appoints former Molina Healthcare CFO Thomas L. Tran to Board and Audit Committee

CLOVER HEALTH INVESTMENTS, CORP. /DE

Thomas L. Tran appointed Class II director and Audit Committee member; Board expanded from 8 to 9.
Tran brings 35+ yrs healthcare finance experience; was CFO of Molina Healthcare (2018-2021) and Upstream Care (2022-2023).
Tran receives pro-rated annual retainer and $200K RSU award for 2024 service under Clover's director compensation policy.
Tran entered standard indemnification agreement; no arrangements or family relationships with officers/directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas L. Tran

Class II director

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2024-08-20
Filed: August 22, 2024, 7:59 PM ET

On August 20, 2024, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Thomas L. Tran, to serve as a Class II director of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Thomas L. Tran was appointed as Class II director at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: Class II director

Exact text from the filing

On August 20, 2024, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Thomas L. Tran, to serve as a Class II director of the Board.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-24-000182

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.